Transplantation, AutologousHematopoietic Stem Cell TransplantationPostoperative ComplicationsTreatment OutcomeTransplantation, HomologousBone Marrow TransplantationCardiac Surgical ProceduresRetrospective StudiesLiver TransplantationTransplantation ConditioningTime FactorsStem Cell TransplantationMultiple MyelomaKidney TransplantationMelphalanHematopoietic Stem Cell MobilizationGraft SurvivalPeripheral Blood Stem Cell TransplantationCombined Modality TherapyCell TransplantationHeart TransplantationLymphoma, Non-HodgkinRecurrenceSalvage TherapyAntigens, CD34Lung TransplantationBone Marrow PurgingCarmustineLeukapheresisAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideGranulocyte Colony-Stimulating FactorGraft vs Host DiseaseWhole-Body IrradiationRemission InductionHematopoietic Stem CellsFollow-Up StudiesSurvival AnalysisDisease-Free SurvivalOrgan TransplantationBlood Transfusion, AutologousEtoposideSurvival RateBusulfanHodgkin DiseaseHematologic NeoplasmsGraft RejectionImmunosuppressive AgentsPancreas TransplantationTissue DonorsIslets of Langerhans TransplantationCytarabineTransplantationTransplantation ImmunologyProspective StudiesGraft vs Tumor EffectFeasibility StudiesMyeloablative AgonistsPrognosisTransplantation ChimeraBone MarrowThalidomideKanamycin KinaseVincristineBlood Component RemovalTransplantation, IsogeneicNeoplasm, ResidualCells, CulturedLiving DonorsLymphomaCell SeparationTransplantation, HeterotopicGenetic TherapyHematopoiesisCord Blood Stem Cell TransplantationIdarubicinPrednisoneBone Marrow CellsAntineoplastic Agents, AlkylatingHeart-Lung TransplantationLeukemiaDexamethasoneLeukemia, Myeloid, AcuteStem CellsColony-Forming Units AssayImmunomagnetic SeparationMyelodysplastic SyndromesBlood Cell CountCell Culture TechniquesPostoperative PeriodGenetic VectorsImmunosuppressionTissue and Organ ProcurementTransplantation ToleranceAntibodies, MonoclonalTransduction, GeneticDoxorubicinAntibodies, Monoclonal, Murine-DerivedHistocompatibility TestingLentivirus